Back
Starbucks Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
44
SBUX
Starbucks
Last Price:
96.15
Seasonality Move:
8.08%
Sell
33
BMRN
Biomarin Pharmaceutical
Last Price:
71.13
Seasonality Move:
5.7%
Sell
44
Starbucks (SBUX)
is a Sell
Is Starbucks a Buy, Sell or Hold?
- The current Starbucks [SBUX] share price is $96.44. The Score for SBUX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- SBUX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $70.55. The Score for BMRN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SBUX Stock Price Chart
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $70.55
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
SBUX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.1 | Buy |
| Relative Strength Index (14 RSI): | 60.91 | Buy |
| Chaikin Money Flow: | 5325254 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (92.36 - 96.9) | Buy |
| Bollinger Bands (100): | (73.73 - 89.95) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.98 | Sell |
| Relative Strength Index (14 RSI): | 20.79 | Sell |
| Chaikin Money Flow: | 1035913 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (81.58 - 93.32) | Sell |
| Bollinger Bands (100): | (78.83 - 88.25) | Sell |
SBUX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 95.69 | Buy |
| 20-day SMA: | 94.69 | Buy |
| 50-day SMA: | 84.87 | Buy |
| 200-day SMA: | 87.31 | Buy |
| 8-day EMA: | 96.11 | Buy |
| 20-day EMA: | 93.64 | Buy |
| 50-day EMA: | 88.31 | Buy |
| 200-day EMA: | 87.42 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 80.97 | Sell |
| 20-day SMA: | 86.7 | Sell |
| 50-day SMA: | 86.17 | Sell |
| 200-day SMA: | 87.12 | Sell |
| 8-day EMA: | 79.59 | Sell |
| 20-day EMA: | 84.09 | Sell |
| 50-day EMA: | 85.42 | Sell |
| 200-day EMA: | 86.31 | Sell |
Starbucks Earnings Growth & SBUX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.07 per share, an increase this year of $0.11 per share, and an increase next year of $0.42 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
Starbucks Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||